A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients

Haematologica. 2015 Dec;100(12):e501-4. doi: 10.3324/haematol.2015.132035. Epub 2015 Aug 20.

¹ Dept. of Haematology, Niguarda Cancer Center, Milan, Italy alessandra.tedeschi@ospedaleniguarda.it.
² Division of Haematology, Department of Translational Medicine, Amedeo Avogadro University of EasternPiedmont, Novara, Italy.
³ Dept. of Haematology, Spedali Civili, Brescia, Italy.
⁴ Haematology and Bone MarrowTransplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
⁵ Dept. of HaematologyOncology, Fondazione IRCCS Policlinico San Matteo &University of Pavia, Italy.
⁶ Division of Haematology, University of Torino, A.O. Città della Salute e della Scienza di Torino, Italy.
⁷ Dept. of Haematology, Humanitas Cancer Center, Rozzano, Italy.
⁸ Haematology Unit, Ospedale San Gerardo, Monza, Italy.
⁹ Dept. of Haematology and BMT Unit, University of Milan, Ospedale Maggiore, Italy.
¹⁰ Internal Medicine Dept., Hospital of Legnano, Italy.
¹¹ Dept. of Onco-Haematology, University Vita-Salute San Raffaele, Milan, Italy.
¹² Dept. of Internal Medicine, Ospedale Valduce, Como, Italy.
¹³ Dept. of Haematology, Niguarda Cancer Center, Milan, Italy.

No abstract available

Keywords: chronic lymphocytic leukemia; cyclophosphamide; elderly; ofatumumab; pentostatin.

Publication types